Perth-headquartered bio-nanotech company pSivida Ltd has completed the recruitment stage of the second phase of a clinical study of cancer treatment technology BrachySil in the treatment of inoperable pancreatic cancer.
13/08/2007 - 17:05
pSivida completes recruitment stage of BrachySil trials
13/08/2007 - 17:05
